Golimbet Vera, Korovaitseva Galina, Lezheiko Tatyana, Abramova L I, Kaleda V G
Mental Health Research Center, Moscow, Russia.
J Affect Disord. 2017 Jan 15;208:604-609. doi: 10.1016/j.jad.2016.10.020. Epub 2016 Oct 26.
Affective syndrome is thought to be a key feature that differentiates schizophrenia from schizoaffective disorder (SA) and bipolar disorder with psychotic features (BDP). However genetic underpinnings of these differences remain unresolved.
We compared clinical variables of affective psychoses (SA, BDP and schizophrenia with affective symptoms (AFF SCZ)) and schizophrenia without affective symptoms (non-AFF SCZ) and searched for a genetic variant that may differentiate affective psychosis from non-AFF SCZ.
A total of 2677 subjects, including 831 patients with affective psychosis, 785 patients with non-AFF SCZ and 1061 healthy controls, were used. Clinical symptoms were assessed with the PANSS. The sample was genotyped for 5-HTTLPR polymorphism of the serotonin transporter gene.
The diagnostic groups differed significantly on demographic and clinical variables. The percentage of men was higher, the current age and age at illness onset were lower in non-AFF SCZ and SA compared to AFF SCZ and BDP. The severity of positive and negative symptoms decreased significantly from group to group in the following manner: non-AFF SCZ>AFF SCZ>SA>BDP. There was the association between 5-HTTLPR polymorphism and affective psychosis (p=0.01). The frequency of the SS genotype was higher in the affective psychosis group compared to non-AFF SCZ and controls. No differences in the genotype distribution were identified between the non-AFF SCZ group and controls.
Difficulties in the differentiation between non-AFF SCZ and AFF SCZ or SA and between AFF SCZ and SA due to uncertain diagnostic boundaries between these conditions.
SA is intermediate between non-AFF SCZ and BDP in the severity of positive and negative symptoms. The first episode patients, carriers of the SS genotype have a higher risk of developing affective psychosis than non-AFF SCZ. This finding carries implications for the prognosis of psychosis outcomes in the first-episode patients.
情感综合征被认为是区分精神分裂症与分裂情感性障碍(SA)以及伴有精神病性特征的双相情感障碍(BDP)的关键特征。然而,这些差异的遗传基础仍未得到解决。
我们比较了情感性精神病(SA、BDP和伴有情感症状的精神分裂症(AFF SCZ))与无情感症状的精神分裂症(非AFF SCZ)的临床变量,并寻找可能区分情感性精神病与非AFF SCZ的基因变异。
共纳入2677名受试者,包括831例情感性精神病患者、785例非AFF SCZ患者和1061名健康对照。使用阳性和阴性症状量表(PANSS)评估临床症状。对样本进行血清素转运体基因5-HTTLPR多态性的基因分型。
各诊断组在人口统计学和临床变量上存在显著差异。与AFF SCZ和BDP相比,非AFF SCZ和SA组男性比例更高,当前年龄和发病年龄更低。阳性和阴性症状的严重程度从一组到另一组显著降低,顺序如下:非AFF SCZ>AFF SCZ>SA>BDP。5-HTTLPR多态性与情感性精神病之间存在关联(p=0.01)。与非AFF SCZ组和对照组相比,情感性精神病组中SS基因型的频率更高。非AFF SCZ组与对照组之间未发现基因型分布的差异。
由于这些疾病之间诊断界限不明确,难以区分非AFF SCZ与AFF SCZ或SA,以及AFF SCZ与SA。
SA在阳性和阴性症状的严重程度上介于非AFF SCZ和BDP之间。首发患者中,SS基因型携带者患情感性精神病的风险高于非AFF SCZ。这一发现对首发患者精神病结局的预后具有重要意义。